반응 #1140125

ord-4b218c9f90154e579b2aebf14743788b

반응 방정식

COc1cccc([C@]2(O)CCCC[C@H]2CN(C)C)c1
(−)-tramadol
COc1ccc2cc([C@H](C)C(=O)O)ccc2c1
(S)-naproxen
COc1ccc2cc([C@H](C)C(=O)O)ccc2c1.COc1cccc([C@]2(O)CCCC[C@H]2CN(C)C)c1
(−)-tramadol (S)-naproxen

시약

없음

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    기타a third of the solvent was evaporated
  2. 2
    workup.WAITwas left
  3. 3
    여과The resulting suspension was filtered off
  4. 4
    세척the filtrate was washed with ca. 1 mL of isopropanol
  5. 5
    기타dried under vacuum (10 mm Hg) at 60° C. for 24 hours

실험 절차

A solution of (−)-tramadol (0.58 g, 2.20 mmol) in 2 mL of isopropanol was added to a stirred suspension of (S)-naproxen (1.02 g, 4.43 mmol, 2 eq) in 2 mL of isopropanol at 60° C. The resulting solution was cooled to room temperature and a third of the solvent was evaporated. The solution was seeded with 5-10 mg of crystalline (−)-tramadol-(S)-naproxen (1:2) co-crystal and was left standing at room temperature for 48 hours without stirring. The resulting suspension was filtered off, the filtrate was washed with ca. 1 mL of isopropanol and dried under vacuum (10 mm Hg) at 60° C. for 24 hours to give the co-crystal (−)-tramadol-(S)-naproxen in a 1:2 ratio as a white solid (1.31 g, 81%).

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US09393220B2uspto-grants-2016_07